RRoche Read More Roche obesity drug shows 22.5% weight loss as it seeks to catch up with Lilly, Novo2026-08-01 Roche obesity drug shows 22.5% weight loss in Phase-II trialRoche focuses on catching Lilly in $150 billion obesity…
